Moderna, Inc. (NASDAQ: MRNA) last traded at $226.30, up 4.65% on the session. The quote above updates while this page is open; the figures below are drawn from Moderna, Inc.’s own filings and are restated only when a new one is published.
Moderna, Inc. trades on NASDAQ under the ticker MRNA. It is classified in the Healthcare sector, Biotech industry. Its market capitalisation is $90.35 billion.
Healthcare sectorBiotechListed on NASDAQ
Valuation measures for Moderna, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $90.35B |
|---|---|
| Enterprise value | $92.82B |
| Price / sales | 40.55 |
| Price / book | 13.36 |
| Beta |
|---|
| 1.99 |
Trailing-twelve-month figures tagged in Moderna, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $2.23B |
|---|---|
| Net income (TTM) | -$3.15B |
| EPS (TTM) | -$7.98 |
| Gross margin | 23.38% |
| Operating margin | -149.01% |
| Return on equity | -46.61% |
| Cash | $1.72B |
Range and volume for MRNA over the past 52 weeks.
| 52-week high | $227.46 |
|---|---|
| 52-week low | $22.28 |
| Volume | 16.58M |
| Average volume | 18.42M |
| Previous close | $216.25 |
Other Healthcare companies tracked on FurlPay Markets.
Invest a chosen dollar amount in Moderna, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell MRNA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.